500 related articles for article (PubMed ID: 33799467)
1. MicroRNAs, Parkinson's Disease, and Diabetes Mellitus.
Wang H
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799467
[TBL] [Abstract][Full Text] [Related]
2. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
3. Modified level of miR-376a is associated with Parkinson's disease.
Baghi M; Rostamian Delavar M; Yadegari E; Peymani M; Pozo D; Hossein Nasr-Esfahani M; Ghaedi K
J Cell Mol Med; 2020 Feb; 24(4):2622-2634. PubMed ID: 31930701
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease.
Tryphena KP; Anuradha U; Kumar R; Rajan S; Srivastava S; Singh SB; Khatri DK
J Alzheimers Dis; 2023; 94(s1):S187-S202. PubMed ID: 35848027
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA machinery in Parkinson's disease: a platform for neurodegenerative diseases.
Saghazadeh A; Rezaei N
Expert Rev Neurother; 2022 Jun; 22(6):427-453. PubMed ID: 26574782
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: Biomarkers for cardiovascular disease in patients with diabetes mellitus.
Briasoulis A; Tousoulis D; Vogiatzi G; Siasos G; Papageorgiou N; Oikonomou E; Genimata V; Konsola T; Stefanadis C
Curr Top Med Chem; 2013; 13(13):1533-9. PubMed ID: 23745805
[TBL] [Abstract][Full Text] [Related]
7. Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics.
Uppala SN; Tryphena KP; Naren P; Srivastava S; Singh SB; Khatri DK
Mech Ageing Dev; 2023 Jul; 213():111826. PubMed ID: 37268278
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs: possible role in pathogenesis of Parkinson's disease.
Filatova EV; Alieva AKh; Shadrina MI; Slominsky PA
Biochemistry (Mosc); 2012 Aug; 77(8):813-9. PubMed ID: 22860903
[TBL] [Abstract][Full Text] [Related]
9. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
[TBL] [Abstract][Full Text] [Related]
10. Regulatory miRNA-mRNA Networks in Parkinson's Disease.
Santos-Lobato BL; Vidal AF; Ribeiro-Dos-Santos Â
Cells; 2021 Jun; 10(6):. PubMed ID: 34204164
[TBL] [Abstract][Full Text] [Related]
11. Systemic Analysis of miRNAs in PD Stress Condition: miR-5701 Modulates Mitochondrial-Lysosomal Cross Talk to Regulate Neuronal Death.
Prajapati P; Sripada L; Singh K; Roy M; Bhatelia K; Dalwadi P; Singh R
Mol Neurobiol; 2018 Jun; 55(6):4689-4701. PubMed ID: 28710704
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson's disease.
Lu J; Xu Y; Quan Z; Chen Z; Sun Z; Qing H
Neuroscience; 2017 Dec; 365():70-82. PubMed ID: 28964753
[TBL] [Abstract][Full Text] [Related]
13. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases.
Saleem A; Javed M; Akhtar MF; Sharif A; Akhtar B; Naveed M; Saleem U; Baig MMFA; Zubair HM; Bin Emran T; Saleem M; Ashraf GM
Curr Gene Ther; 2024; 24(2):122-134. PubMed ID: 37861022
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive bioinformatic analysis revealed novel MicroRNA biomarkers of Parkinson's disease.
Rahimpour A; Heidarzadehpilehrood R; Abdollahi S; Ranjbari H; Shams Z; Ghasemi SA; Najmaei S; Pirhoushiaran M
Cell Biol Int; 2022 Nov; 46(11):1841-1851. PubMed ID: 36098337
[TBL] [Abstract][Full Text] [Related]
15. The Potential Regulation of A-to-I RNA Editing on Genes in Parkinson's Disease.
Wu S; Xue Q; Qin X; Wu X; Kim P; Chyr J; Zhou X; Huang L
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107677
[TBL] [Abstract][Full Text] [Related]
16. Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes.
Grieco GE; Brusco N; Licata G; Nigi L; Formichi C; Dotta F; Sebastiani G
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861156
[TBL] [Abstract][Full Text] [Related]
17. Role of MicroRNAs in Parkinson's Disease.
Goh SY; Chao YX; Dheen ST; Tan EK; Tay SS
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31718095
[TBL] [Abstract][Full Text] [Related]
18. Insight into miRNAs related with glucometabolic disorder.
Zhang BH; Shen CA; Zhu BW; An HY; Zheng B; Xu SB; Sun JC; Sun PC; Zhang W; Wang J; Liu JY; Fan YQ
Biomed Pharmacother; 2019 Mar; 111():657-665. PubMed ID: 30611990
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in Parkinson's disease.
Singh A; Sen D
Exp Brain Res; 2017 Aug; 235(8):2359-2374. PubMed ID: 28526930
[TBL] [Abstract][Full Text] [Related]
20. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
